Lawrence S. Neinstein, M.D., F.A.C.P.
Professor of Pediatrics and Medicine
USC Keck School of Medicine
Executive Director
University Park Health Center
Associate Dean of Student Affairs



Substance Abuse - Web Sites/References (B8)

Go to web sites
Go to references

Go to substance abuse - intro/categories/prevalence/etiology
Go to substance abuse - alcohol/cigarettes/marijuana/hallucinogens
Go to substance abuse - stimulants/inhalants/opioids/depressants/anabolic steroids/designer and club drugs
Go to substance abuse - management of drug abuse
Go to substance abuse - questions/cases
Go to substance abuse - web sites/references

Web Sites
The National Institute on Drug Abuse has extensive resources for providers on treatment. These can all be obtained at the above web site
Information on Anabolic steroids from National Institute on Drug Abuse Cocaine/Cocaine.html
information on cocaine/crack
information on heroin
Infofax (NIDA) on ecstasy
Infofax on PCP
Infofax on LSD
Infofax on Club Drugs
Infofax on rohypnol/GHB
National Clearinghouse on Alcohol and Drug Information
CDC site on tobacco
Smokescreen: National advocacy web site
Surgeon General's website for smoking cessation
U.S. Department of Health and Human Services web site on tobacco
American Lung Association site for and by teens
NIH facts for teens
NIH facts on marijuana for parents
National Clearinghouse for Alcohol and Drug Information, Center for Substance Abuse Prevention: This resource was produced as part of the Girl Power! program for girls ages 9 to 14 years. The fact sheet presents a general overview of marijuana use; the short-term and long-term effects of marijuana use and other related facts.
NIH information on side effects of hallucinogens
Information from National Institute on Drug Abuse on many drugs

back to top


Ammerman, SD. Helping kids kick butts. Contemporary Pediatrics 1998; 15(2): 64.

Baldrige EB, Bessen HA. Phencyclidine. Emerg Med Clin North Am 1990;8:541.

Bartechhi CE, MacKenzie TD, Schrier RW. The human costs of tobacco use (two parts) N Engl J med 1994;330;907, 975.

Bauer UE, Johnson TM, Hopkins RS, et al. Changes in youth cigarette use and intentions following implementation of a tobacco control program: findings from the Florida youth tobacco survey, 1998-2000. JAMA. 2000;284(6):723.

Bauman A, Phongsavan P. Epidemiology of substance use in adolescence: prevalence, trends and policy implications. Drug & Alcohol Dependence. 1999;55:187.

Bergmann PE, Smith MB, Hoffmann NG. Adolescent treatment: implications for assessment, practice guidelines, and outcome management. Pediatr Clin North Am 1995;42:453.

Biener L, Harris JE, Hamilton W. Impact of the Massachusetts tobacco control program: population based trend analysis. BMJ. 2000;321:351.

Brundtland GH. Achieving worldwide tobacco control. JAMA. 2000;284(6):750.

Burgess C, O'Donohoe A, Gill M. Agony and ecstasy: a review of MDMA effects and toxicity. European Psychiatry: J Association European Psychiatrists. 2000;15:287.

Centers for Disease Control and Prevention (CDC): Youth Tobacco Surveillance United States, 1998-1999. Mor Mortal Wkly Rep, CDC Surveill Summ. October 13, 2000; 49:SS-10.

Centers for Disease Control and Prevention (CDC): Mor Mortal Wkly Rep, CDC Surveill Summ. Medical care expenditures attributable to cigarette smoking United States , 1993. 1994;43:469-72.

Centers for Disease Control and Prevention (CDC): Trends in cigarette smoking among high school students. Mor Mortal Wkly Rep, CDC Surveill Summ. August 25 2000;49(33):755.

Centers for Disease Control and Prevention (CDC): Youth risk behavior surveillance United States , 1999. Mor Mortal Wkly Rep, CDC Surveill Summ. June 9, 2000;49(SS-5).

Chait LD, Perry JL. Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. Psychopharmacology 1994;115: 340.

Channabasavanna S, Paes M, Hall W. Psychiatric and behavioural effects of cannabis. In: Kalant H, Corrigal W, Hall W, Smart R. The health effects of cannabis. Toronto : Addiction Research Foundation, 1998.

Clark PI, Natanblut, SL, Schmitt CL, et al. Factors associated with tobacco sales to minors: lessons learned from the FDA compliance checks. JAMA. 2000;284(6):729.

Comerci GD, Schwebel R. Substance abuse: an overview. Adolescent Medicine. 2000;11:79

Court JM. Cannabis and brain function. J Paediatrics Child Health. 1998;34:1.

Crowley TJ, Macdonald MJ, Whitmore EA, Mikulich SK. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug Alcohol Depend. 1998;50:27.

Cuomo MJ, Dyment PG, Gammino VM. Increasing use of "ecstasy" (MDMA) and other hallucinogens on a college campus. J Am Coll Health 1994;42:271.

Curran HV. Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology. 2000;42:34.

Dinwiddie SH. Abuse of inhalants: a review. Addiction 1994;89:925.

Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: a clinical practice guideline. Rockville , Md : US Dept of Health and Human Services; 2000: AHRQ Publication No. 00-0032.

Franklin JE. Addiction medicine. JAMA 1995;273:1656.

Fuller PG JR, Cavanaugh RM Jr. Basic assessment and screening for substance abuse in the pediatrician's office. Pediatr Clin North Am 1995;42:295.

Glantz SA. The truth about big tobacco in its own words. BMJ. 2000;321:313.

Graham AW, Schultz TK, Principles of Addiction Medicine, American Society of Addiction Medicine, Chevy Chase Maryland , 1998.

Gray JD. Medical consequences of cocaine. Can Fam Physician Med Fam Can 1993;39:1975.

Hall W, Solowij N. Adverse effects of cannabis Lancet. 1998;352:1611.

Hall W, Solowij N, Lemon J. The health and psychological consequences of cannabis use. National Drug Strategy Monograph Series no 25. Canberra : Australian Government Publishing Service, 1994.

Halpern JH, Pope HG Jr. Do hallucinogens cause residual neuropsychological toxicity?. Drug & Alcohol Dependence. 1999;53:247.

Hogan MJ. Diagnosis and treatment of teen drug use. Med Clin North Am. 2000;84:927.

Hollander JE, Burstein JL, Hoffman RS, et al. Cocaine-associated myocardial infarction. Clinical safety of thrombolytic therapy. Cocaine Associated Myocardial Infarction (CAMI) Study Group. Chest 1995; 107:1237.

Houston T, Kaufman NJ . Tobacco control in the 21 st century: searching for answers in a sea of change. JAMA. 2000;284(6):752.

Johnston LD, O'Malley PM, Bachman JG. Results of Monitoring the Future Study, Ann Arbor News and Information Services of the University of Michigan , December 2000.

Johnston LD, O'Malley PM, Bachman JG. Monitoring the Future: National Results on Adolescent Drug Use: Overview of Key Findings, 2000. US Department of Health and Human Services. 2001

Johnson JG, Cohen P, Pine DS, et al. Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. JAMA. 2000:284(18);2348.

Johnston LD, O'Malley PM, Bachman JG. Monitoring the Future: National Results on Adolescent Drug Use, 1975 1999, Volume I: Secondary School Students, 1999.U.S. Department of Health and Human Services. 2000

Johnston LD, O'Malley PM, Bachman JG. Monitoring the Future: National Results on Adolescent Drug Use: Overview of Key Findings, 2000. US Department of Health and Human Services. 2001

Kessler DA. Nicotine addiction in young people. N Engl J Med 1995;333:186.

Konings E, DuboiArber F, Narring F, et al. Identifying adolescent drug users: results of a national survey on adolescent health in Switzerland . J Adolesc Health 1995;16:240.

Lancaster T, Stead L, Silagy C, et al. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library . BMJ. 2000;321:355.

Li J, Stokes SA. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management, Ann Emerg Med, 1998;31:729.

McGee R, Williams S, Poulton R et al. A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction. 2000;95:491.

McGuire P. Long term psychiatric and cognitive effects of MDMA use. Toxicology Letters. 2000;112-113:153.

MacDonald DI. Patterns of alcohol and drug use among adolescents. In: Rogers PD, ed. Symposium on chemical dependency. Pediatr Clin North Am 1987;34:275.

Meyers K. Hagan TA. Zanis D et al. Critical issues in adolescent substance use assessment. Drug Alcohol Dependence. 1999;55:235.

Morland J. Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use. Toxicology Letters. 2000;112-113:147.

Mouhaffel AH, Madu EC, Satmary WA , et al. Cardiovascular complications of cocaine. Chest 1995;107: 1426.

Morrison SF, Rogers PD, Thomas MH. Alcohol and adolescents. Pediatr Clin North Am 1995;42:371.

National Consensus Developmetn Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA 1998;280:1936.

National Household Survey of Drug Abuse: Summary of Findings from the 1999 National Household Survey on Drug Abuse. Department of Health and Human Services.

National Household Survey of Drug Abuse: Summary of Findings from the 1999 National Household Survey on Drug Abuse. Department of Health and Human Services.

National Institute on Alcohol Abuse and Alcoholism. Assessing Alcohol Problems: A Guide for Clinicians and Researchers. NIAAA Treatment Handbook Series 4. 1995, Bethesda , MD. NIH Publication #95-3745. 573 pp.

National Institute on Alcohol Abuse and Alcoholism (NIAAA), U.S. Department of Health & Human Services. Imaging and Alcoholism: A Window on the Brain. Alcohol Alert, 2000 Apr;47:1-3. [Online]

National Institute on Drug Abuse. Ecstasy: Infofax,

Neinstein LS: Adolescent Health Care: A Practical Guide, 4 th Edition including chapters:

Chapter 69 Overview of Drug Use and Abuse Neinstein LS and Heischober BS

Chapter 70 Alcohol Neinstein LS and Anderson M

Chapter 71 Tobacco Ammerman S, and Neinstein LS

Chapter 72 Marijuana Neinstein LS and Heischober BS

Chapter 73 Hallucinogens Neinstein LS and Heischober BS

Chapter 74 Miscellaneous Drugs Neinstein LS, Heischober BS, Pinsky D

Chapter 75 Approaches to Management of Drug Abuse Neinstein LS and Pinsky D

O'Connor PG. Treating opioid dependence New data and new opportunities. N Eng J Med. 2000;343:1332.

O'Malley PM, Johnston LD, Bachman JG. Adolescent substance use: epidemiology and implications for public policy. Pediatr Clin North Am 1995;42:241.

Pope HG, Yurgelun-Todd D. The residual congitive effects of heavy marijuana use. JAMA 1996;275:521.

Porcerelli JH, Sandler BA. Anabolic-androgenic steroid abuse and psychopathology. Psych Clin N Am. 1998;21:829.

Prabhat J, Chaloupka FJ. The economics of global tobacco control. BMJ. 2000;321:358.

Rigotti NA, Lee JE, Wechsler H. US college students' use of tobacco products: results of a national survey. JAMA. 2000;284(6):699.

Rogers PD, Speraw SR, Ozbek I. Assessment of the identified substance-abusing adolescent. Pediatr Clin North Am 1995;42:351.

Rojas N, Killen JD, Haydel KF, Robinson TN. Nicotine dependence and withdrawal symptoms in adolescent smokers. Arch Ped Adol Med. 1998; 152:151.

Schiller MJ, Shumway M, Batki SL. Utility of routine drug screening in a psychiatric emergency setting. Psychiatric Services. 2000;51:474.

Schwartz RH, Miller NS. MDMA(ecstasy) and the rave: a review, Pediatrics. 1997;100:705.

Shiono PH, Klebanoff MA, Nugent RP, et al. The impact of cocaine and marijuana use on low birth weight and preterm birth; a multicenter study. Am J Obstet Gynecol 1995;172:19.

Stein MD. Medical consequences of substance abuse. Psych Clin N Am. 1999;22:351.

Sullivan ML,. Martinez CM,. Gennis P et al. The cardiac toxicity of anabolic steroids. Prog Cardiovascular Dis. 1998;41:1.

Tanner SM, Miller DW, Alongi C. Anabolic steroid use by adolescents: prevalence, motives, and knowledge of risks. Clin J Sports Med 1995;5:108.

Tashkin DP, Fligiel S, Wu JTC, et al. Effects of habitual use of marijuana and/or cocaine on the lung. NIDA Research Monograph 1990;99:63.

Thun M, Glynn TJ. Improving the treatment of tobacco dependence. BMJ. 2000;321:311.

U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. Health , United States , 2000. Adolescent Health Chartbook.

Weaver MF, Jarvis MA, Schnoll SH. Role of the primary care physician in problems of substance abuse. Arch Int Med. 1999;159:913.

Weir E. Raves: a review of the culture, the drugs and the prevention of harm CMAJ. 2000;162:1843.

Werner MJ. Principles of brief intervention for adolescent alcohol, tobacco, and other drug use. Pediatr Clin North Am 1995;42:335.

Wichstrom I. Predictors of adolescent suicide attempts: a nationally representative longitudinal study of Norwegian adolescents. J Am Acad Child Adolesc Psychiatry, 2000;39:603.

Willens HJ, Chakko SC , Kessler KM. Cardiovascular manifestations of cocaine abuse: a case of recurrent dilated cardiomyopathy. Chest 1994;106:594.

Windle M, Windle RC. Adolescent tobacco, alcohol, and drug use: current findings. Adolescent Medicine. 1999;10:153.

Woolf AD, Shannon MW Clinical toxicology for the pediatrician. Pediatr Clin North Am 1995;42:317.

back to top

Copyright (©) 2004-2013 Lawrence S. Neinstein, University of Southern California . All rights reserved. Republication or redistribution of the text, table, graphs and photos is expressly prohibited. The University of Southern California shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.